abstract |
The present invention features charge-modified antidepressants and compounds that are attached to either charged groups or bulky groups in a manner that is not susceptible to in vivo cleavage. The present invention provides a method for treating a patient by administering a compound of the present invention to the patient having an inflammatory disease. |